Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Beta2-adrenergic receptor genetics.

B A Raby¹, S T Weiss

¹Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Restw@channing.harvard.edu

Current Opinion in Molecular Therapeutics

|January 24, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasma metabolite profiles in children with current asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018

Same author

Soluble ST2 regulation by rhinovirus and 25(OH)-vitamin D3 in the blood of asthmatic children.

Clinical and experimental immunology·2018

Same author

MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.

Leukemia·2017

Same author

PTTG1IP and MAML3, novel genomewide association study genes for severity of hyperresponsiveness in adult asthma.

Allergy·2016

Same author

Vitamin D and bronchopulmonary dysplasia in preterm infants.

Journal of perinatology : official journal of the California Perinatal Association·2016

Same author

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

The New England journal of medicine·2016

Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011

Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010

Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010

Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010

Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010

Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010

See all related articles

Genetic variations in the beta2-adrenergic receptor (beta2AR) gene influence lung function and drug responses, but are not a primary cause of asthma. Further research on gene haplotypes is needed to understand their full impact.

Area of Science:

Pharmacogenetics
Pulmonary Medicine
Molecular Genetics

Background:

The beta2-adrenergic receptor (beta2AR) gene, located on chromosome 5q31-33, is a candidate gene for asthma.
Seventeen known polymorphisms exist within the beta2AR gene, complicating functional significance assessment.
Previous studies often lacked haplotypic analysis, hindering a comprehensive understanding of gene function.

Purpose of the Study:

To investigate the functional significance of beta2AR gene polymorphisms.
To determine the role of beta2AR gene variations in asthma susceptibility and lung function.
To explore the pharmacogenetic effects of beta2AR gene polymorphisms.

Main Methods:

Analysis of 17 known polymorphisms in the beta2AR gene.

Related Experiment Videos

Functional assays assessing the impact of polymorphisms.

Haplotypic assessment to understand combined effects of polymorphisms.

Main Results:

The beta2AR gene is not identified as a primary asthma-susceptibility gene.
Beta2AR gene variations appear to be a minor determinant of lung function.
Significant pharmacogenetic effects associated with beta2AR gene polymorphisms were observed.

Conclusions:

Further research is required to elucidate the complete effects of beta2AR gene haplotypes on receptor function.
Understanding haplotype effects is crucial for defining impacts on disease phenotype and pharmacogenetics.
The beta2AR gene plays a role in lung function and drug response, but not as a major asthma gene.